DDInter496 DDInter1544
A potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1.
Prucalopride is a dihydrobenzofurancarboxamide derivative from the benzofurane family that selectively stimulates 5-HT4 receptors and thus, it presents enterokinetic properties. The high selectivity of prucalopride allowed further development as it prevented the cardiac adverse reactions observed due to non-target effects of precedent therapies. Prucalopride was developed by Shire Development LLC and approved for use in Europe in 2009, in Canada on December 7, 2011 and by the FDA on December 17, 2018.
Delavirdine {u} (Compound) treats {v} (Disease) acquired immunodeficiency syndrome
Delavirdine {u} (Compound) binds {v} (Gene) CYP3A7-CYP3A51P
Delavirdine {u} (Compound) is included by {v} (Pharmacologic Class) Non-Nucleoside Reverse Transcriptase Inhibitors
Delavirdine {u} (Compound) causes {v} (Side Effect) Paralysis
Delavirdine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Teniposide
Delavirdine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Darolutamide
Delavirdine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Binimetinib
Delavirdine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pantoprazole
Delavirdine {u} may lead to a major life threatening interaction when taken with {v} Midostaurin
Delavirdine {u} may lead to a major life threatening interaction when taken with {v} Terfenadine
Delavirdine (Compound) treats acquired immunodeficiency syndrome (Disease)
Delavirdine (Compound) binds CYP3A7-CYP3A51P (Gene)
Delavirdine (Compound) is included by Non-Nucleoside Reverse Transcriptase Inhibitors (Pharmacologic Class)
Delavirdine (Compound) causes Paralysis (Side Effect)
Delavirdine may cause a minor interaction that can limit clinical effects when taken with Teniposide
Delavirdine may cause a minor interaction that can limit clinical effects when taken with Darolutamide
Delavirdine may cause a moderate interaction that could exacerbate diseases when taken with Binimetinib
Delavirdine may cause a moderate interaction that could exacerbate diseases when taken with Pantoprazole
Delavirdine may lead to a major life threatening interaction when taken with Midostaurin
Delavirdine may lead to a major life threatening interaction when taken with Terfenadine